Candriam Equities L Biotech.V2 USD Acc/ LU2026682919 /
| NAV03/06/2024 | Chg.+31.6000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 1,845.2800USD | +1.74% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 04/06/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 01/03/2024 | PRIIP Key Information Document | 2024 | English | 260.07 KB |
| 01/03/2024 | PRIIP Key Information Document | 2024 | German | 268.40 KB |
| 31/12/2023 | Account statment | 2023 | English | 5,416.37 KB |
| 31/12/2023 | Account statment | 2023 | German | 4,732.66 KB |
| 11/09/2023 | Prospectus | 2023 | English | 3,638.77 KB |
| 11/09/2023 | Prospectus | 2023 | German | 3,801.35 KB |
| 30/06/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 30/06/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 02/07/2022 | Key Investor Information | 2022 | English | 353.30 KB |
| 02/07/2022 | Key Investor Information | 2022 | German | 357.88 KB |
